These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31968134)

  • 1. Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate-Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study.
    Alarkawi D; Ali MS; Bliuc D; Pallares N; Tebe C; Elhussein L; Caskey FJ; Arden NK; Ben-Shlomo Y; Abrahamsen B; Diez-Perez A; Pascual J; Pérez-Sáez MJ; Center JR; Judge A; Cooper C; Javaid MK; Prieto-Alhambra D
    J Bone Miner Res; 2020 May; 35(5):894-900. PubMed ID: 31968134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis.
    Robinson DE; Ali MS; Pallares N; Tebé C; Elhussein L; Abrahamsen B; Arden NK; Ben-Shlomo Y; Caskey FJ; Cooper C; Dedman D; Delmestri A; Judge A; Pérez-Sáez MJ; Pascual J; Nogues X; Diez-Perez A; Strauss VY; Javaid MK; Prieto-Alhambra D
    J Bone Miner Res; 2021 May; 36(5):820-832. PubMed ID: 33373491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.
    Robinson DE; Ali MS; Strauss VY; Elhussein L; Abrahamsen B; Arden NK; Ben-Shlomo Y; Caskey F; Cooper C; Dedman D; Delmestri A; Judge A; Javaid MK; Prieto-Alhambra D
    Health Technol Assess; 2021 Mar; 25(17):1-106. PubMed ID: 33739919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Khalid S; Calderon-Larranaga S; Sami A; Hawley S; Judge A; Arden N; Van Staa TP; Cooper C; Abrahamsen B; Javaid MK; Prieto-Alhambra D
    Osteoporos Int; 2022 Jul; 33(7):1579-1589. PubMed ID: 35138412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK.
    de Bruin IJA; Wyers CE; Souverein PC; van Staa TP; Geusens PPMM; van den Bergh JPW; de Vries F; Driessen JHM
    Osteoporos Int; 2020 Aug; 31(8):1487-1497. PubMed ID: 32266436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density.
    Rodríguez AJ; Ernst MT; Nybo M; Prieto-Alhambra D; Ebeling PR; Hermann AP; Abrahamsen B
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32717068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between renal function and BMD response to bisphosphonate treatment: Real-world cohort study using linked national registers.
    Abrahamsen B; Ernst MT; Smith CD; Nybo M; Rubin KH; Prieto-Alhambra D; Hermann AP
    Bone; 2020 Aug; 137():115371. PubMed ID: 32334104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases.
    Tan EH; Rathod-Mistry T; Strauss VY; O'Kelly J; Giorgianni F; Baxter R; Brunetti VC; Pedersen AB; Ehrenstein V; Prieto-Alhambra D
    J Bone Miner Res; 2024 Aug; 39(7):844-854. PubMed ID: 38619297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Risk and Mortality in Patients With Kidney Disease: A Population-Based Cohort Study.
    Kitchlu A; Reid J; Jeyakumar N; Dixon SN; Munoz AM; Silver SA; Booth CM; Chan CTM; Garg AX; Amir E; Kim SJ; Wald R
    Am J Kidney Dis; 2022 Oct; 80(4):436-448.e1. PubMed ID: 35405208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of osteoporosis medications on bone fracture in patients with chronic kidney disease.
    Kao CC; Wu PC; Chuang MT; Yeh SC; Lin YC; Chen HH; Fang TC; Chang WC; Wu MS; Chang TH
    Postgrad Med J; 2023 May; 99(1170):340-349. PubMed ID: 37227976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Khalid S; Calderon-Larrañaga S; Hawley S; Ali MS; Judge A; Arden N; van Staa T; Cooper C; Javaid MK; Prieto-Alhambra D
    Clin Epidemiol; 2018; 10():1417-1431. PubMed ID: 30349390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study.
    Cowan A; Jeyakumar N; McArthur E; Fleet JL; Kanagalingam T; Karp I; Khan T; Muanda FT; Nash DM; Silver SA; Thain J; Weir MA; Garg AX; Clemens KK
    J Bone Miner Res; 2023 May; 38(5):650-658. PubMed ID: 36970786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
    Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
    Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.
    Malmgren L; McGuigan FE; Berglundh S; Westman K; Christensson A; Åkesson K
    Nephron; 2015; 130(4):245-55. PubMed ID: 26184510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease.
    Hall RK; Sloane R; Pieper C; Van Houtven C; LaFleur J; Adler R; Colón-Emeric C
    J Am Geriatr Soc; 2018 Mar; 66(3):532-538. PubMed ID: 29319880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.